BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:14 PM
Sep 04, 2012
 |  BC Extra  |  Company News

Valeant to acquire Medicis for $2.6B

Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX) will acquire dermatology company Medicis Pharmaceutical Corp. (NYSE:MRX) for $44 per share in cash, which values Medicis at about $2.6 billion based on 59.8 million shares outstanding at Aug. 6. The...

Read the full 174 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >